The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Additionally, the recalled Classic Potato Chips have the UPC 28400 31041 and both the “Guaranteed Fresh” date of Feb. 5, 2025 ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Nine states have been identified as being affected by the chocolate recall, but the products were available online so others ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...